申请人:Stichting Het Nederlands Kanker Instituut-
Antoni van Leeuwenhoek Ziekenhuis
公开号:EP3875452A1
公开(公告)日:2021-09-08
Provided are compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof:
Also provided are compositions comprising compounds of formula (I). The compounds and compositions are also provided for use as medicaments, for example as medicaments useful in the treatment of a condition modulated by monoacylglycerol lipase (MAGL). Also provided are the use of compounds and compositions for the inhibition of monoacylglycerol lipase (MAGL).